Comparison of the molecular genetics ofc-erb-B2 and p53 expression in stomach cancer in Britain and Japan
Open Access
- 15 February 1995
- Vol. 75 (4) , 920-925
- https://doi.org/10.1002/1097-0142(19950215)75:4<920::aid-cncr2820750405>3.0.co;2-e
Abstract
Background. Differences in the epidemiology and treatment outcome of stomach cancer have led to the suggestion that in Japan, this disease may be biologically less aggressive than that found in the West. The authors compared p53b and c‐erb‐B2 expression, trying to identify genetic differences in Japanese compared with Western stomach cancers. Methods. Paraffin embedded formalin fixed tissues from 89 British and 89 matched Japanese patients were examined by immunohistochemistry after microwave treatment. Cases were matched for T‐stage, year of surgery, and histopathologic grade. Results. Tumors from 48 British and 46 Japanese patients expressed p53, whereas those of 27 British and 28 Japanese patients expressed c‐erb‐B2. No significant difference in the density or distribution of protein expression was found between the two populations. The distribution of expression between diffuse and intestinal types and the proportion of cases expressing both antigens were similar in the two groups. Conclusions. p53 and c‐erb‐B2 are expressed in the same way in stomach carcinomas from Japanese and British patients. This study found no evidence of genetic differences in the cancers from the two countries. Cancer 1995;75:920‐5.Keywords
This publication has 20 references indexed in Scilit:
- British Stomach Cancer Group MeetingGut, 1993
- Adenocarcinoma of the stomach: are we making progress?The Lancet, 1993
- Molecular mechanism of stomach carcinogenesisZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- An immunohistochemical study of c‐erbb‐2 protein in gastric carcinomas and lymph‐node metastases: Is the c‐erbB‐2 protein really a prognostic indicator?International Journal of Cancer, 1993
- A technique for retrieving antigens in formalin-fixed, routinely acid-decalcified, celloidin-embedded human temporal bone sections for immunohistochemistry.Journal of Histochemistry & Cytochemistry, 1992
- c-erbB-2 oncogene product expression and prognosis in gastric carcinoma.Journal of Clinical Pathology, 1992
- p53 expression and prognosis in gastric carcinomaInternational Journal of Cancer, 1992
- Clinicopathological significance of c‐erbB‐2 protein expression in human gastric carcinomaJournal of Surgical Oncology, 1992
- c‐erbB‐2 proto‐oncogene expression and its relationship to survival in gastric carcinoma: An immunohistochemical study on archival materialInternational Journal of Cancer, 1991
- Gastric cancer: Different diseasesBritish Journal of Surgery, 1989